The Bioanalytical Contract Research Laboratory Makes Third Appearance in Prestigious Ranking
AUGUST 18, 2016—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has been named to Inc. Magazine’s Inc. 5000 list of America’s fastest-growing private companies. This year’s Inc. 5000 award winners were selected and ranked from a pool of companies that are U.S. based, privately held, for profit, and independent. Each company’s place on the list was determined by the percentage growth of its annual revenue from 2012 to 2015. BioAgilytix ranks among the nation’s most successful entrepreneurial businesses.
This is not the first time BioAgilytix has been honored with a ranking on the Inc. 5000 list, coming in at #1341 for 2013 and #1943 for 2014. The company’s consistent appearance on the list reflects the proactive approach it has taken to meet growing customer demands for preclinical, clinical, and manufacturing support for pharmacokinetic, immunogenicity, cell-based assay, and biomarker studies. A focused commitment to strategic, methodical expansion and continual innovation have enabled BioAgilytix to continually deliver world-leading science, service, and quality to its pharmaceutical and biotech clients, and have the company poised to remain a member of the Inc. 5000 list in the future.
“It is exciting to be selected among the U.S.’ most successful private companies for a third time,” said Jim Datin, Chief Executive Officer of BioAgilytix. “It reaffirms that the core strategy we’ve built this business on since its founding in 2008 – to hire great people and give them the tools they need to succeed – is working, and shows that with such focus you can achieve great things. We’re proud that as a team we have been able to bring the BioAgilytix name to the forefront alongside other prestigious brands on the Inc. 5000 list, and are striving to further our growth, and ranking, in the upcoming years.”
All 5,000 honoree companies are individually profiled on Inc.com, and the 35th Annual Inc. 5000 Conference and Gala will be held October 18 through 20, 2016 in San Antonio, Texas to honor all of this year’s listed companies.
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, GLP, GCP, and GCLP, as well as product release testing under GMP.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 23 of the top 25 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.